Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Sep-24 4:30 PM View:  | Good Jennifer L Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 17-Sep-24 | Option Exercise | 31,751 | $21.54 | $684,066.00 | 1058% 3.0K to 34.75K | |
| 19-Sep-24 4:30 PM View: | Good Jennifer L Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 17-Sep-24 | Planned Option Sale | 31,751 | $52.40 | $1,663,800.00 | (91%) 34.75K to 3.0K | |
| 11-Sep-24 4:31 PM View: | Tetrault Lynn A. Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 10-Sep-24 | Option Exercise | 17,501 | $10.51 | $183,944.00 | 583% 3.0K to 20.5K | |
| 11-Sep-24 4:31 PM View: | Tetrault Lynn A. Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 10-Sep-24 | Planned Option Sale | 17,501 | $49.65 | $868,923.00 | (85%) 20.5K to 3.0K | |
| 11-Sep-24 4:32 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Sep-24 | Planned Option Sale | 4,099 | $50.03 | $205,062.00 | (23%) 17.6K to 13.5K | |
| 11-Sep-24 4:30 PM View: | Good Jennifer L Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Sep-24 | Option Exercise | 37,241 | $13.34 | $496,706.00 | 1241% 3.0K to 40.24K | |
| 11-Sep-24 4:30 PM View: | Good Jennifer L Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Sep-24 | Planned Option Sale | 37,241 | $50.45 | $1,878,700.00 | (93%) 40.24K to 3.0K | |
| 11-Sep-24 4:32 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Sep-24 | Option Exercise | 4,099 | $19.02 | $77,963.00 | 30% 13.5K to 17.6K | |
| 11-Sep-24 4:31 PM View: | Tetrault Lynn A. Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Sep-24 | Option Exercise | 3,199 | $18.99 | $60,749.00 | 107% 3.0K to 6.2K | |
| 11-Sep-24 4:31 PM View: | Tetrault Lynn A. Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Sep-24 | Planned Option Sale | 3,199 | $50.04 | $160,068.00 | (52%) 6.2K to 3.0K | |
| 28-Aug-24 4:30 PM View: | Good Jennifer L Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 26-Aug-24 | Option Exercise | 14,508 | $18.63 | $270,322.00 | 484% 3.0K to 17.51K | |
| 28-Aug-24 4:30 PM View: | Good Jennifer L Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 26-Aug-24 | Planned Option Sale | 14,508 | $50.01 | $725,526.00 | (83%) 17.51K to 3.0K | |
| 28-Aug-24 4:31 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 26-Aug-24 | Option Exercise | 3,200 | $19.02 | $60,864.00 | 24% 13.5K to 16.7K | |
| 28-Aug-24 4:31 PM View: | Tetrault Lynn A. Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 26-Aug-24 | Option Exercise | 4,300 | $18.99 | $81,657.00 | 143% 3.0K to 7.3K | |
| 28-Aug-24 4:31 PM View: | Tetrault Lynn A. Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 26-Aug-24 | Planned Option Sale | 4,300 | $50.01 | $215,029.00 | (59%) 7.3K to 3.0K | |
| 28-Aug-24 4:31 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 26-Aug-24 | Planned Option Sale | 3,200 | $50.01 | $160,018.00 | (19%) 16.7K to 13.5K | |
| 14-Aug-24 4:15 PM View: | Tetrault Lynn A. Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 12-Aug-24 | Planned Option Sale | 10,000 | $44.65 | $446,462.00 | (77%) 13.0K to 3.0K | |
| 14-Aug-24 4:15 PM View: | Tetrault Lynn A. Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 12-Aug-24 | Option Exercise | 10,000 | $4.15 | $41,500.00 | 333% 3.0K to 13.0K | |
| 13-Aug-24 4:45 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Aug-24 | Planned Option Sale | 30,771 | $45.15 | $1,389,230.00 | (49%) 62.51K to 31.73K | |
| 13-Aug-24 4:45 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Aug-24 | Option Exercise | 30,771 | $19.02 | $585,264.00 | 97% 31.73K to 62.51K | |
| 13-Aug-24 4:45 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-Aug-24 | Sale (Planned) | 18,235 | $45.15 | $823,264.00 | (57%) 31.73K to 13.5K | |
| 30-Jul-24 5:09 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 29-Jul-24 | Planned Option Sale | 1,395 | $49.06 | $68,438.70 | (4%) 33.13K to 31.73K | |
| 30-Jul-24 5:09 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 26-Jul-24 | Option Exercise | 3,125 | -- | -- | 10% 30.0K to 33.13K | |
| 18-Jul-24 5:59 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Jul-24 | Option Exercise | 10,468 | $27.35 | $286,300.00 | 34893% 30 to 10.5K | |
| 18-Jul-24 5:59 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Jul-24 | Planned Option Sale | 10,468 | $53.00 | $554,817.00 | (100%) 10.5K to 30 | |
| 16-Jul-24 4:30 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 12-Jul-24 | Planned Option Sale | 5,313 | $50.01 | $265,725.00 | (99%) 5.34K to 30 | |
| 16-Jul-24 4:30 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 12-Jul-24 | Option Exercise | 5,313 | $21.38 | $113,592.00 | 17710% 30 to 5.34K | |
| 25-Jun-24 10:00 PM View: | Mathers Edward T Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 21-Jun-24 | Option Exercise | 3,000 | -- | -- | 52% 5.77K to 8.77K | |
| 25-Jun-24 4:35 PM View: | Jean Christophe Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 21-Jun-24 | Option Exercise | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 25-Jun-24 4:39 PM View: | McGirr David W J Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 21-Jun-24 | Option Exercise | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 25-Jun-24 4:37 PM View: | Bedrosian Camille L Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 21-Jun-24 | Option Exercise | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 25-Jun-24 4:38 PM View: | Tetrault Lynn A. Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 21-Jun-24 | Option Exercise | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 25-Jun-24 4:41 PM View: | Arbuckle Stuart A Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 21-Jun-24 | Option Exercise | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 25-Jun-24 4:30 PM View: | Good Jennifer L Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 21-Jun-24 | Option Exercise | 3,000 | -- | -- | 100% 0 to 3.0K | |
| 13-May-24 4:21 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-May-24 | Option Exercise | 3,984 | $6.80 | $27,091.20 | 13280% 30 to 4.01K | |
| 13-May-24 4:21 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 09-May-24 | Planned Option Sale | 3,984 | $38.47 | $153,259.00 | (99%) 4.01K to 30 | |
| 16-Apr-24 8:11 PM View: | Mazabraud Yann EVP, Head of International | Rhythm Pharmaceuticals, Inc. (RYTM) | 14-Apr-24 | Option Exercise | 10,375 | -- | -- | (23%) 45.24K to 34.87K | |
| 03-Apr-24 8:00 PM View: | German Christopher Paul Corporate Controller & CAO | Rhythm Pharmaceuticals, Inc. (RYTM) | 02-Apr-24 | Planned Option Sale | 368 | $41.76 | $15,367.70 | (32%) 1.16K to 0.8K | |
| 22-Mar-24 4:55 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 21-Mar-24 | Private Sale (Planned) | 18,235 | $40.34 | $735,600.00 | (100%) 18.27K to 30 | |
| 22-Mar-24 4:16 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 20-Mar-24 | Private Sale (Planned) | 18,235 | $38.77 | $707,005.00 | (73%) 25.09K to 6.85K | |
| 03-Apr-24 8:00 PM View: | German Christopher Paul Corporate Controller & CAO | Rhythm Pharmaceuticals, Inc. (RYTM) | 20-Mar-24 | Option Exercise | 1,163 | -- | -- | 100% 0 to 1.16K | |
| 19-Mar-24 8:53 PM View: | Mazabraud Yann EVP, Head of International | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 16,000 | $39.22 | $627,520.00 | (40%) 40.49K to 24.5K | |
| 19-Mar-24 8:50 PM View: | Cramer Pamela J. Chief Human Resources Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 15,515 | $39.22 | $608,498.00 | (34%) 45.52K to 30.0K | |
| 19-Mar-24 8:57 PM View: | Smith Hunter C Chief Financial Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 15,515 | $39.22 | $608,498.00 | (14%) 113.45K to 97.94K | |
| 19-Mar-24 8:54 PM View: | Meeker David P President and CEO Director | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 45,494 | $39.22 | $1,784,270.00 | (21%) 220.1K to 174.6K | |
| 19-Mar-24 8:52 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 15,515 | $39.22 | $608,498.00 | (38%) 40.6K to 25.09K | |
| 19-Mar-24 8:56 PM View: | Shulman Joseph Chief Technical Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 19-Mar-24 | Private Sale (Planned) | 15,515 | $39.22 | $608,498.00 | (46%) 33.78K to 18.27K | |
| 21-Feb-24 7:02 PM View: | Mazabraud Yann EVP, Head of International | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Feb-24 | Grant | 33,750 | -- | -- | 500% 6.75K to 40.49K | |
| 21-Feb-24 7:01 PM View: | Smith Hunter C Chief Financial Officer | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Feb-24 | Grant | 33,750 | -- | -- | 42% 79.7K to 113.45K | |
| 21-Feb-24 7:00 PM View: | Chien Jennifer EVP, Head of North America | Rhythm Pharmaceuticals, Inc. (RYTM) | 16-Feb-24 | Grant | 33,750 | -- | -- | 493% 6.85K to 40.6K |
